Related Experiment Video
Updated: Feb 20, 2026

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis
1State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Abstract:
Epithelial-mesenchymal transition (EMT) is a process during which normal epithelial cells acquire mesenchymal characteristics. EMT has a critical role in various human diseases especially in cancer. EMT facilitates tumor initiation and progression by mediating cancer cell stemness and motility. Zinc finger transcription factor SNAIL is one of the most important initiators of EMT. Therefore, it is of great significance to understand the regulating mechanism of SNAIL. In this study, we carried out a luciferase-based genome-wide screening using small interfering RNA library against ~200 of E3 ligases and ubiquitin-related genes and identified SOCS box protein SPSB3 as a novel E3 ligase component that targets SNAIL into polyubiquitination and degradation in response to GSK-3β phosphorylation of SNAIL. Functionally, we observed that SPSB3 overexpression greatly inhibits tumor metastasis by regulating SNAIL degradation both in vitro and in vivo. The expression of SPSB3 and SNAIL are negatively correlated in human esophageal squamous cell carcinoma tissues, and low SPSB3 expression indicates lymph node metastasis. Moreover, high SPSB3 expression indicates good survivals in various kinds of cancer. Collectively, these findings suggest that SPSB3-mediated SNAIL degradation has a vital role in regulating EMT and cancer progression.
Insights
Scientists discovered that SPSB3 protein degrades SNAIL, a key factor in cancer spread. This finding offers new insights into controlling epithelial-mesenchymal transition (EMT) and cancer progression, potentially improving patient survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for cancer initiation and progression.
- SNAIL, a zinc finger transcription factor, is a key regulator of EMT.
- Understanding SNAIL's regulation is vital for developing cancer therapies.
Purpose of the Study:
- To identify novel regulators of SNAIL.
- To investigate the role of E3 ligases in SNAIL degradation.
- To explore the therapeutic potential of targeting SNAIL regulation in cancer.
Main Methods:
- Genome-wide screening using a small interfering RNA library against E3 ligases and ubiquitin-related genes.
- Luciferase-based assay to identify SNAIL regulators.
- In vitro and in vivo experiments to assess the function of identified regulators.
- Analysis of patient tissues to correlate gene expression with clinical outcomes.
Main Results:
- SOCS box protein SPSB3 was identified as a novel E3 ligase targeting SNAIL for degradation.
- SPSB3 promotes SNAIL polyubiquitination and degradation, particularly after GSK-3β phosphorylation of SNAIL.
- SPSB3 overexpression inhibits tumor metastasis in vitro and in vivo.
- SPSB3 and SNAIL expression are negatively correlated in esophageal squamous cell carcinoma.
- Low SPSB3 expression correlates with lymph node metastasis and poor survival in various cancers.
Conclusions:
- SPSB3-mediated SNAIL degradation is a critical mechanism regulating EMT and cancer progression.
- SPSB3 acts as a tumor suppressor by inhibiting metastasis.
- SPSB3 expression levels can serve as a prognostic biomarker for various cancers.
- Targeting the SPSB3-SNAIL axis presents a potential therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Destabilization of Microtubules
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization

